Seer, Inc. (SEER)
Nasdaq · Laboratory Analytical Instruments · Manufacturing · CIK 1726445 · fiscal year ends in Dec
Closing price $1.69 on 30 Oct 2026; 52-week range $1.62 to $2.34.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $14.2M
- Revenue growth
- -12.7%
- Net income, last twelve months
- -$68.0M
- Earnings per share
- -$1.22
- Gross margin
- 47.7%
- Operating margin
- -498.2%
- Net margin
- -478.0%
- Free cash flow
- -$44.2M
- Return on equity
- -30.1%
- Market value
- $93.3M
- Dividend yield
- 0.0%
- Cash
- $26.1M
- Debt
- $0
- Debt to equity
- 0.00
- Shares outstanding
- 55.4M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $16.6M | -$78.0M | -$73.6M | -$1.28 | -$46.2M | 10-K filed 2 Mar 2026 |
| FY2024 | 31 Dec 2024 | $14.2M | -$100.1M | -$86.6M | -$1.39 | -$49.7M | 10-K filed 3 Mar 2025 |
| FY2023 | 31 Dec 2023 | $16.7M | -$103.5M | -$86.3M | -$1.35 | -$66.4M | 10-K filed 4 Mar 2024 |
| FY2022 | 31 Dec 2022 | $15.5M | -$97.2M | -$93.0M | -$1.49 | -$71.0M | 10-K filed 6 Mar 2023 |
| FY2021 | 31 Dec 2021 | $6.6M | -$71.5M | -$71.2M | -$1.17 | -$53.3M | 10-K filed 1 Mar 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $3.1M | -$16.9M | -$0.31 |
| Q1 FY2026 | 31 Mar 2026 | $2.8M | -$16.8M | -$0.30 |
| Q4 FY2025 | 31 Dec 2025 | $4.2M | -$16.0M | -$0.29 |
| Q3 FY2025 | 30 Sep 2025 | $4.1M | -$18.2M | -$0.32 |
| Q2 FY2025 | 30 Jun 2025 | $4.1M | -$19.4M | -$0.33 |
| Q1 FY2025 | 31 Mar 2025 | $4.2M | -$19.9M | -$0.34 |
| Q4 FY2024 | 31 Dec 2024 | $4.0M | -$21.7M | -$0.37 |
| Q3 FY2024 | 30 Sep 2024 | $4.0M | -$21.3M | -$0.35 |
Company events
The newest 8-K filings of 60 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 29 Oct 2026 | 8-K | Other events | 8.01, 9.01 |
| 18 Sep 2026 | 8-K | Leadership change | 5.02 |
| 11 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 31 Jul 2026 | 8-K | Shareholder vote | 5.07 |
| 31 Jul 2026 | 8-K | Other events | 8.01, 9.01 |
| 20 Jul 2026 | 8-K | Other events | 8.01, 9.01 |
| 2 Jul 2026 | 8-K | Other events | 8.01, 9.01 |
| 22 May 2026 | 8-K | Other events | 8.01, 9.01 |
| 13 May 2026 | 8-K | Results | 2.02, 9.01 |
| 4 May 2026 | 8-K | Other events | 8.01, 9.01 |
| 27 Apr 2026 | 8-K | Other events | 8.01, 9.01 |
| 13 Apr 2026 | 8-K | Other events | 8.01, 9.01 |
Every filing
The newest filings with the SEC of 179 held.
| Filed | Form | Period |
|---|---|---|
| 29 Oct 2026 | 8-K | 29 Oct 2026 |
| 18 Sep 2026 | 8-K | 14 Sep 2026 |
| 11 Aug 2026 | 10-Q | 30 Jun 2026 |
| 11 Aug 2026 | 8-K | 11 Aug 2026 |
| 31 Jul 2026 | 8-K | 28 Jul 2026 |
| 31 Jul 2026 | 8-K | 28 Jul 2026 |
| 28 Jul 2026 | DFAN14A | – |
| 24 Jul 2026 | DFAN14A | – |
| 22 Jul 2026 | DEFA14A | – |
| 22 Jul 2026 | DFAN14A | – |
| 20 Jul 2026 | DEFA14A | – |
| 20 Jul 2026 | 8-K | 20 Jul 2026 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 18 Aug 2026 | Horn David R., PRESIDENT & CFO | Sale outside a trading plan | 7,309 | $2.03 | $14.8K | 486,650 | 19 Aug 2026 |
| 8 Jul 2026 | Nishar Dipchand, Director | Sale under a trading plan | 10,660 | $2.18 | $23.3K | 59,044 | 10 Jul 2026 |
| 20 May 2026 | Horn David R., PRESIDENT & CFO | Sale outside a trading plan | 7,303 | $1.69 | $12.4K | 493,959 | 21 May 2026 |
| 18 Feb 2026 | Horn David R., PRESIDENT & CFO | Sale outside a trading plan | 7,743 | $1.99 | $15.4K | 501,262 | 19 Feb 2026 |
| 18 Feb 2026 | Farokhzad Omid, CEO AND CHAIR | Sale outside a trading plan | 24,385 | $1.99 | $48.6K | 3,349,064 | 19 Feb 2026 |
| 19 Nov 2025 | Horn David R., PRESIDENT & CFO | Sale outside a trading plan | 6,797 | $1.97 | $13.4K | 436,802 | 21 Nov 2025 |
| 19 Nov 2025 | Farokhzad Omid, CEO AND CHAIR | Sale outside a trading plan | 33,838 | $1.97 | $66.7K | 1,238,230 | 21 Nov 2025 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 8 Jul 2026 | DIPCHAND NISHAR, Director | 10,660 | $23.3K | 8 Jul 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 15 May 2026 | Omid Farokhzad | 13G amended | 12% | 6.9M |
| 4 May 2026 | Invus Public Equities, L.P. | 13G amended | 4.4% | 2.5M |
| 13 Apr 2026 | Radoff Family Foundation | 13D amended | 4.6% | 2.6M |
| 2 Mar 2026 | Radoff Family Foundation | 13D amended | 4.6% | 2.6M |
| 20 Feb 2026 | Radoff Family Foundation | 13D | 3.7% | 2.1M |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 94.4K | -13.07% | 1 |
| 30 Sep 2026 | 108.6K | +24.36% | 1 |
| 15 Sep 2026 | 87.3K | -40.09% | 1 |
| 31 Aug 2026 | 145.8K | +18.49% | 1 |
| 14 Aug 2026 | 123.0K | -32.21% | 1 |
| 31 Jul 2026 | 181.5K | +22.58% | 1 |
| 15 Jul 2026 | 148.1K | +13.46% | 1 |
| 30 Jun 2026 | 130.5K | -31.93% | 1 |
Funds that hold it
From each fund's latest Form 13F.
67 funds held it at 30 Jun 2026: 23 added and 19 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| Softbank Group Corp. | 5,135,383 | $8.5M | 0 |
| Siren, L.L.C. | 2,458,673 | $4.1M | 0 |
| Acadian Asset Management LLC | 1,953,704 | $3.2M | -121,005 |
| Vanguard Capital Management LLC | 1,831,058 | $3.0M | -127,938 |
| BlackRock, Inc. | 1,428,405 | $2.4M | -393,199 |
| Renaissance Technologies LLC | 985,500 | $1.6M | +8,812 |
| Nano Cap New Millennium Growth Fund L P | 825,000 | $1.4M | 0 |
| Citadel Advisors LLC | 519,310 | $862.1K | +519,310 |
| Two Sigma Investments, LP | 492,298 | $817.2K | -19,300 |
| Geode Capital Management, LLC | 460,430 | $764.5K | +37,453 |
Peers
Companies in the same industry.
- Agilent Technologies, Inc. (A): revenue $7.4B, market value $49.3B
- Waters Corp. (WAT): revenue $4.6B, market value $45.4B
- Mettler Toledo International Inc. (MTD): revenue $4.1B, market value $36.3B
- Illumina, Inc. (ILMN): revenue $4.5B, market value $35.7B
- Revvity, Inc. (RVTY): revenue $2.9B, market value $17.5B
- Avantor, Inc. (AVTR): revenue $6.6B, market value $10.9B
- Bio-Rad Laboratories, Inc. (BIO): revenue $2.6B, market value $10.0B
- 10x Genomics, Inc. (TXG): revenue $616.9M, market value $9.1B
- Bruker Corp. (BRKR): revenue $3.5B, market value $8.7B
- Alamar Biosciences, Inc. (ALMR): revenue –, market value $2.1B